Suppr超能文献

计算洞察 SARS-CoV-2 刺突蛋白的别构效应和动态结构特征。

Computational Insights into the Allosteric Effect and Dynamic Structural Features of the SARS-COV-2 Spike Protein.

机构信息

State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, P. R. China.

College of Resources and Environment, University of the Chinese Academy of Sciences, Beijing, 100049, P. R. China.

出版信息

Chemistry. 2022 Jan 27;28(6):e202104215. doi: 10.1002/chem.202104215. Epub 2022 Jan 19.

Abstract

COVID-19 caused by SARS-COV-2 is continuing to surge globally. The spike (S) protein is the key protein of SARS-COV-2 that recognizes and binds to the host target ACE2. In this study, molecular dynamics simulation was used to elucidate the allosteric effect of the S protein. Binding of ACE2 caused a centripetal movement of the receptor-binding domain of the S protein. The dihedral changes in Phe329 and Phe515 played a key role in this process. Two potential cleavage sites S1/S2 and S2' were exposed on the surface after the binding of ACE2. The binding affinity of SARS-COV-2 S protein and ACE2 was higher than that of SARS-COV. This was mainly due to the mutation of Asp480 in SARS-COV to Ser494 in SARS-COV-2, which greatly weakened the electrostatic repulsion. The result provides a theoretical basis for the SARS-COV-2 infection and aids the development of biosensors and detection reagents.

摘要

由 SARS-CoV-2 引起的 COVID-19 在全球范围内继续激增。刺突(S)蛋白是 SARS-CoV-2 的关键蛋白,它识别并结合宿主靶标 ACE2。在这项研究中,使用分子动力学模拟来阐明 S 蛋白的变构效应。ACE2 的结合导致 S 蛋白受体结合域的向心运动。二面角变化 Phe329 和 Phe515 在该过程中起关键作用。在与 ACE2 结合后,S1/S2 和 S2'两个潜在的切割位点暴露在表面上。SARS-CoV-2 S 蛋白和 ACE2 的结合亲和力高于 SARS-CoV。这主要是由于 SARS-CoV 中的 Asp480 突变为 SARS-CoV-2 中的 Ser494,大大减弱了静电排斥。该结果为 SARS-CoV-2 感染提供了理论依据,并有助于生物传感器和检测试剂的开发。

相似文献

1
Computational Insights into the Allosteric Effect and Dynamic Structural Features of the SARS-COV-2 Spike Protein.
Chemistry. 2022 Jan 27;28(6):e202104215. doi: 10.1002/chem.202104215. Epub 2022 Jan 19.
2
SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.
Proc Natl Acad Sci U S A. 2022 Jan 4;119(1). doi: 10.1073/pnas.2111199119.
3
SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.
Elife. 2021 Feb 8;10:e63646. doi: 10.7554/eLife.63646.
4
Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Comput Biol Chem. 2022 Feb;96:107613. doi: 10.1016/j.compbiolchem.2021.107613. Epub 2021 Dec 1.
5
Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
Proteins. 2021 Sep;89(9):1134-1144. doi: 10.1002/prot.26086. Epub 2021 Apr 26.
6
Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.
J Biomol Struct Dyn. 2021 Jul;39(10):3605-3614. doi: 10.1080/07391102.2020.1768150. Epub 2020 May 20.

本文引用的文献

1
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Cell Rep. 2021 Jun 29;35(13):109292. doi: 10.1016/j.celrep.2021.109292. Epub 2021 Jun 8.
2
Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2.
Biophys J. 2021 Jul 20;120(14):2859-2871. doi: 10.1016/j.bpj.2021.02.049. Epub 2021 May 11.
4
Molecular Architecture of the SARS-CoV-2 Virus.
Cell. 2020 Oct 29;183(3):730-738.e13. doi: 10.1016/j.cell.2020.09.018. Epub 2020 Sep 6.
5
Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
ACS Nano. 2020 Aug 25;14(8):10616-10623. doi: 10.1021/acsnano.0c04798. Epub 2020 Aug 4.
6
Structures and distributions of SARS-CoV-2 spike proteins on intact virions.
Nature. 2020 Dec;588(7838):498-502. doi: 10.1038/s41586-020-2665-2. Epub 2020 Aug 17.
7
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
Science. 2020 Sep 4;369(6508):1261-1265. doi: 10.1126/science.abc0870. Epub 2020 Aug 4.
8
Mapping allosteric communications within individual proteins.
Nat Commun. 2020 Jul 31;11(1):3862. doi: 10.1038/s41467-020-17618-2.
9
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
Science. 2020 Sep 18;369(6510):1505-1509. doi: 10.1126/science.abc5881. Epub 2020 Jul 23.
10
Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis.
J Med Virol. 2021 Feb;93(2):820-830. doi: 10.1002/jmv.26326. Epub 2020 Aug 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验